Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.24% | -8.59% | -9.06% | -12.93% | -13.77% |
| Total Other Revenue | -- | -- | -- | -- | -6.02% |
| Total Revenue | -6.24% | -8.59% | -9.06% | -12.93% | -14.42% |
| Cost of Revenue | -11.11% | -11.51% | -17.38% | -15.41% | -2.89% |
| Gross Profit | 3.35% | -3.05% | 8.25% | -8.26% | -30.62% |
| SG&A Expenses | 6.60% | 15.19% | 15.58% | 14.90% | 17.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.35% | 4.25% | 2.40% | 2.50% | 5.10% |
| Operating Income | -7.24% | -19.60% | -16.92% | -24.98% | -38.02% |
| Income Before Tax | -6.97% | -21.74% | -9.56% | -32.04% | -21.82% |
| Income Tax Expenses | -7,088.19% | -1,648.15% | -945.00% | 2.65% | 19.91% |
| Earnings from Continuing Operations | 35.31% | -19.58% | -9.09% | -31.92% | -21.81% |
| Earnings from Discontinued Operations | 66.48% | 30.93% | 15.71% | -121.26% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.07% | -2.94% | -1.56% | -47.56% | -86.03% |
| EBIT | -7.24% | -19.60% | -16.92% | -24.98% | -38.02% |
| EBITDA | -33.66% | -22.16% | -16.86% | -19.01% | -22.34% |
| EPS Basic | 64.26% | 52.28% | 64.50% | 64.34% | 41.45% |
| Normalized Basic EPS | 3.78% | 27.92% | 58.29% | 66.94% | 71.85% |
| EPS Diluted | 64.26% | 52.61% | 64.87% | 64.68% | 42.04% |
| Normalized Diluted EPS | 3.78% | 27.92% | 58.29% | 66.94% | 71.85% |
| Average Basic Shares Outstanding | 8.06% | 35.63% | 82.33% | 181.50% | 346.12% |
| Average Diluted Shares Outstanding | 8.06% | 35.63% | 82.33% | 181.50% | 346.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |